Clinical Trial Update: Efficacy of a 2'-Fucosylactose-based Food Supplement on the Prevention of Respiratory and Gastrointestinal Infections. [NA]

View source ↗

Summary

A clinical trial is evaluating whether a 2'-Fucosyllactose-based food supplement can prevent respiratory and gastrointestinal infections; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteritis
• Respiratory Tract Infection

Drugs mentioned

• 2'-Fucosyllactose-based food supplement (2'-Fucosyllactose)

Snippet

Sponsor: University of Bari | Conditions: Gastroenteric Tract, Respiratory Tract | NA | Status: RECRUITING